1. Home
  2. AMC vs SDGR Comparison

AMC vs SDGR Comparison

Compare AMC & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Entertainment Holdings Inc.

AMC

AMC Entertainment Holdings Inc.

HOLD

Current Price

$2.83

Market Cap

993.9M

ML Signal

HOLD

SDGR

Schrodinger Inc.

HOLD

Current Price

$15.29

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMC
SDGR
Founded
1920
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
993.9M
1.1B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
AMC
SDGR
Price
$2.83
$15.29
Analyst Decision
Hold
Buy
Analyst Count
4
9
Target Price
$2.03
$21.00
AVG Volume (30 Days)
49.9M
860.2K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.14
EPS
N/A
N/A
Revenue
$4,848,900,000.00
$255,869,000.00
Revenue This Year
$11.41
$0.76
Revenue Next Year
$5.18
$4.60
P/E Ratio
N/A
N/A
Revenue Growth
4.57
23.29
52 Week Low
$0.93
$10.95
52 Week High
$3.26
$23.02

Technical Indicators

Market Signals
Indicator
AMC
SDGR
Relative Strength Index (RSI) 70.16 47.85
Support Level $1.66 $14.61
Resistance Level $2.96 $16.47
Average True Range (ATR) 0.23 0.60
MACD 0.07 -0.08
Stochastic Oscillator 83.71 31.94

Price Performance

Historical Comparison
AMC
SDGR

About AMC AMC Entertainment Holdings Inc.

AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. The company owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: